Table 3:

Resource utilization rates and costs for breast cancer treatment

Health stateYearResourceResource utilization rate (per person)Mean cost (95% CI), $
Low-risk breast cancer1Surgery1.007312 (7111 to 7512)
Genetic testing*0.512719 (2480 to 2957)
Systemic therapy0.593008 (2085 to 3931)
Radiotherapy0.514283 (3893 to 4667)
End-of-life breast cancer careNR0
2SurgeryNR85 (17 to 153)
Systemic therapy0.531577 (999 to 2156)
Radiotherapy054 (−22 to 131)
End-of-life breast cancer careNR0
3Surgery0.0640 (−16 to 96)
Systemic therapy0.48450 (123 to 776)
RadiotherapyNR90 (−50 to 231)
End-of-life breast cancer careNR0
4Surgery0213 (−206 to 634)
Systemic therapy0.50241 (137 to 346)
Radiotherapy0.01120 (−50 to 288)
End-of-life breast cancer careNR214 (−106 to 634)
5Surgery079 (−77 to 235)
Systemic therapy0.48516 (−251 to 1285)
Radiotherapy00
End-of-life breast cancer careNR0
6–40Continue year 5
High-risk breast cancer1Surgery0.967881 (7547 to 8216)
Systemic therapy0.9819 664 (17 496 to 21 832)
Radiotherapy0.799019 (8457 to 9581)
End-of-life breast cancer careNR274 (−106 to 655)
2Surgery0.02111 (10 to 213)
Systemic therapy0.837718 (5736 to 9699)
RadiotherapyNR285 (102 to 468)
End-of-life breast cancer careNR277 (−107 to 621)
3Surgery00
Systemic therapy0.764004 (1967 to 6312)
RadiotherapyNR106 (0 to 212)
End-of-life breast cancer careNR960 (124 to 1795)
4Surgery00
Systemic therapy0.701574 (404 to 2743)
Radiotherapy0.01112 (−14 to 237)
End-of-life breast cancer careNR984 (−124 to 2095)
5Surgery00
Systemic therapy0.701619 (−76 to 3314)
Radiotherapy00
End-of-life breast cancer careNR647 (−630 to 1925)
6–40Continue year 5
  • Note: CI = confidence interval, NR = not reportable (results for fewer than 10 individuals are not reported).

  • * Score based on genetic testing that predicts 10-year recurrence rate for breast cancer and patient response to chemotherapy.